Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Aldoss

Showing results (61-70 of 233) with videos related to

Pageof 24
Sort By:
Therapeutics and Clinical Risk Management|September 8, 2016
Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adultsKum Ja Lee, Vivian Chow, Ashley Weissman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALLTamer Othman, Aaron C Logan, Lori Muffly, et al.
Medical Oncology (Northwood, London, England)|October 19, 2013
An effective reinduction regimen for first relapse of adult acute lymphoblastic leukemiaIbrahim Aldoss, Vinod Pullarkat, Ravindra Patel, et al.
European Journal of Haematology|June 23, 2015
Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemiaIbrahim Aldoss, Dan Douer, Carolyn E Behrendt, et al.
Blood Advances|August 2, 2022
Interferon-γ blockade in CAR T-cell therapy-associated macrophage activation syndrome/hemophagocytic lymphohistiocytosisMichael Rainone, Dat Ngo, John H Baird, et al.
Hematological Oncology|November 12, 2021
Immunophenotype of acute lymphoblastic leukemia in minorities- analysis from the SEER databaseElisa Quiroz, Aparajit Ram Venkateswaran, Rebecca Nelson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2016
Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaIbrahim Aldoss, Karl Gaal, Monzr M Al Malki, et al.
Leukemia & Lymphoma|March 20, 2020
The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvementSalman Otoukesh, Jianying Zhang, Ryotaro Nakamura, et al.
Bone Marrow Transplantation|May 16, 2019
Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemiaIbrahim Aldoss, Ryotaro Nakamura, Dongyun Yang, et al.
American Journal of Hematology|February 1, 2021
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agentsTamer A Othman, Matthew Mei, Jianying Zhang, et al.
Pageof 24

Showing results (61-70 of 233) with videos related to

Sort By:
Pageof 24
Therapeutics and Clinical Risk Management|September 8, 2016
Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adultsKum Ja Lee, Vivian Chow, Ashley Weissman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALLTamer Othman, Aaron C Logan, Lori Muffly, et al.
Medical Oncology (Northwood, London, England)|October 19, 2013
An effective reinduction regimen for first relapse of adult acute lymphoblastic leukemiaIbrahim Aldoss, Vinod Pullarkat, Ravindra Patel, et al.
European Journal of Haematology|June 23, 2015
Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemiaIbrahim Aldoss, Dan Douer, Carolyn E Behrendt, et al.
Blood Advances|August 2, 2022
Interferon-γ blockade in CAR T-cell therapy-associated macrophage activation syndrome/hemophagocytic lymphohistiocytosisMichael Rainone, Dat Ngo, John H Baird, et al.
Hematological Oncology|November 12, 2021
Immunophenotype of acute lymphoblastic leukemia in minorities- analysis from the SEER databaseElisa Quiroz, Aparajit Ram Venkateswaran, Rebecca Nelson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2016
Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaIbrahim Aldoss, Karl Gaal, Monzr M Al Malki, et al.
Leukemia & Lymphoma|March 20, 2020
The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvementSalman Otoukesh, Jianying Zhang, Ryotaro Nakamura, et al.
Bone Marrow Transplantation|May 16, 2019
Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemiaIbrahim Aldoss, Ryotaro Nakamura, Dongyun Yang, et al.
American Journal of Hematology|February 1, 2021
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agentsTamer A Othman, Matthew Mei, Jianying Zhang, et al.
Pageof 24